6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology

6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology Banner


Date & Location
Monday, October 8, 2018, 7:00 AM - Wednesday, October 10, 2018, 1:00 PM, Rockefeller Research Laboratories 430 E 67th St, New York, NY

Target Audience
Medical Oncology, Molecular Pathology, Neurosurgery, Orthopaedic Surgery, Pathology, Pediatric Oncology, Pediatric Surgery, Radiation Oncology, Radiology-Diagnostic, Radiology-Interventional, Research Fellow, Spine Surgery, Surgical Oncology, Surgical Pathology

Overview

IMPORTANT:
Unfortunately due to unforeseen circumstances, the 6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology course has been canceled.
We apologize for the inconvenience and if you would like to be notified of future course dates, please contact cme@mskcc.org.

--

The 6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology is designed to give a current review of musculoskeletal tumor pathology and principles of management to orthopaedic surgeons, radiologists, pathologists, pediatric oncologists, medical oncologists and radiation oncologists.

This course covers the most common and clinically relevant benign and malignant musculoskeletal tumors, primary and metastatic, from diagnosis to integrated treatment and outcome. Emphasis is placed on clinic-radiographic and pathologic correlations, natural history and biology, multidisciplinary management, standard treatment and novel approaches.

Course Topics:

  • Benign Non Surgical & Surgical Lesions - Aneurysmal Bone Cyst, Bone Cyst, Chondromyxoid Fibroma, Chondroblastoma, Chondromas, Desmoplastic fibroma, Eosinophilic granuloma, Fibrous dysplasia, Giant cell tumor, Histiocytic fibroma, Myositis ossificans, Osteoblastoma, Osteochondromas, Osteoid osteoma
  • Malignant Tumors - Adamantinoma, Chondrosarcomas, Chordoma, Ewing’s sarcoma, Lymphoma, Myeloma, Osteosarcomas, Secondary Malignancies, Spindle and Pleomorphic Sarcomas, Vascular Tumors, Bone Metastases
  • Soft Tissue Tumors - Lipoma and Other Benign Soft Tissue Tumors, Liposarcoma, Fibrosarcoma, Malignant Fibrous Histiocytoma, Synovial Sarcomal, Rare Entities
  • Various - Biological Prognostic and Therapeutic Markers, Bone Allografts in Skeletal Reconstruction, Chemotherapy Issues and Future Trends, Integrated Treatment of Soft Tissue Sarcomas, Reconstruction in Children, Staging and Biopsy and Margins, Surgical Principles of Benign Lesions, Surgical Treatment of Spine Tumors
  • Special Sessions - Basic Research, Molecular Biology in the Diagnosis of Bone and Soft Tissue Tumors, Imaging of Bone and Soft Tissue Tumors, Limb Salvage Surgery

This course is in collaboration with the Hospital for Special Surgery (New York) and the Galeazzi Institute (Milan, Italy).



Objectives
  1. Enhance diagnostic tools based on clinical-radiographic-pathologic correlation.
  2. Enhance knowledge of tumor biology and relationship with treatment principles.
  3. Understand principles of multidisciplinary management.
  4. Refine knowledge of surgical management, with emphasis on limb salvage.

Registration

Unfortunately due to unforeseen circumstances, the 6th Annual Course in Musculoskeletal Tumor Pathology and Clinical Oncology course has been canceled. We apologize for the inconvenience and if you would like to be notified of future course dates, please contact cme@mskcc.org.



Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.